Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

Marico - The strongest branding play - Antique

Posted On: 2012-11-01 20:27:52

A strong play on rural consumerism

Our interactions across our five sample states, re-affirmed our belief in Marico's dominance in coconut and hair oils. The company is capitalising on the opportunity of shift in preference towards branded coconut and hair oils in rural markets. This would be done through expanding its rural exposure during the last three years from about 27% to the current 32%.

Strong pricing power to aid margins

Pricing power of Parachute coconut oil, its key profit generator has been the success factor during the past few years. The brands strength and pricing power led to a substantial 454 bps improvement in Marico's margins from 8.8% in FY05 to 12.9% in FY08. Additionally during FY11 and FY12, years of steep inflation, the brand re-affirmed its strength by recording a volume growth of 11% despite a price hike of 32% in the last 12 months. During FY13, we expect the pricing power of Parachute coupled with drop in copra prices to expand EBITDA margins by 204bps to 14.2%.

Increasing dominance in coconut oil

Marico witnessed a marked improvement over its long term performance by gaining ground in the coconut oil segment where market shares across companies normally remain stagnant. In the coconut oil category Parachute gained about 300bps market share during 1QFY13.

Gaining ground in value added hair oils

Marico has successfully expanded the value added hair oils business through aggressive marketing and entry in to newer categories. This in turn has led to market share gains to the tune of 780bps to 24.8% during the last 5 years. Our channel checks suggest that a majority of the market share gains have been led by improvement in the South Indian market.

Acquisition of Paras Pharma's personal care biz to aid scalability

The acquisition provides the company meaningful entry in a fast growing category like Deodorant and strengthens its market share in hair styling gel and creams. The acquisition also provides Marico an entry in to a better margin profile business when compared to its existing business like hair oils and health based edible oil. Parachute coconut oil nevertheless has a high margin profile.

Valuation

We maintain our earnings estimates for FY13e and FY14e at INR7.2 and INR8.6 respectively. At the CMP of INR203, the stock is trading at a PE of 28.3x FY13e and 23.5x FY14e. We maintain our target price of INR198. In the current scenario, we don't see any scope for further upgrade in the stock or any case for further re-rating. We therefore maintain our HOLD rating on the stock with a target price of INR198.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Views on Yes Bank 1QFY2016 Results: Angel Broking
Views on JSW Steel 1QFY2016 Results: Angel Broking
Views on United Phosphorus Ltd 1QFY2016 Results: Angel Broking
Power Finance Corporation - Cheap valuations factor in concerns - Angel Broking
Federal Bank - Q1FY16 Result Update - Sushil Finance
Bajaj Auto - 1QFY2016 Result Update - Angel Broking
Crompton Greaves - 1QFY2016 Result Update - Angel Broking
Rallis India - 1QFY2016 Result Update - Angel Broking
Views on Maruti Suzuki 1QFY2016 Results: Angel Broking
India Auto: Tyre Segment - Revving up: AnandRathi Research
Views on Ambuja Cement 2QCY2015 Results: Angel Broking
Views on Tech Mahindra 1QFY2016 Results: Angel Broking
Views on TVS Motors 1QFY2016 Results: Angel Broking
India Infrastructure - Reforms signal all systems go! - Religare
Views on Lupin - Updates: Angel Broking
Views on Wipro 1QFY2016 Results: Angel Broking
View on Lupin Limited 1QFY2016 Results: Angel Broking
Views on Bajaj Auto 1QFY2016 Results: Angel Broking
Views on Ceat Ltd 1QFY2016 Results: Angel Broking
View on Sanofi India 2QCY2015 Results: Angel Broking
Views on Eicher Motors 2QCY2015 Results: Angel Broking
Views on HDFC Bank 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals Update: Angel Broking
Views on Infosys 1QFY2016 Results: Angel Broking
Views on Rane Brake Liners 1QFY2016 Results: Angel Broking
Views on Ultratech Cement 1QFY2015 Results: Angel Broking
Views on Lupin - get USFDA approval for Prandimet: Angel Broking
Views on NPPA - Update: Angel Broking
BUY Unichem Laboratories: Anand Rathi Research
Views on Hindustan Media Ventures Ltd 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals: Angel Broking
Views on Dr. Reddys announces the Launch of Memantine Hydrochloride Tablets: Angel Broking
JM Financial buy reccomendation on Shriram Transport Finance Company
Styrolution ABS (India) - Company Update - Angel Broking
KNR Constructions - Road laid for a sustainable drive - Angel Broking
Views on Wipro Digital to Enhance Digital Transformation Capability with Designit: Angel Broking
Views on TCS 1QFY2016 Results: Angel Broking
Views on Tech Mahindra inks strategic pact with PNMsoft: Angel Broking
Views on Infosys signs multi-year agreement with Deutsche Bank: Angel Broking
India Auto sales in June 2015 - Microsec
Alembic Pharma, Lupin & Sun Pharma get approval for Desvenlafaxine Succinate: Angel Broking
Views on Zydus Cadila receives Market Authorisation (MA) from USFDA for Morphine Sulfate ER Tablets: Angel Broking
India Economy Core infrastructure - Sharp recovery in core, may not be sustainable - Anand Rathi Financial Services
Views on Tech Mahindra - Investor Update: Angel Broking
BUY Welspun India - Anand Rathi Retail Research
BUY Persistent Systems - Anand Rathi Research
Alembic Pharmaceuticals - Gets tentative approval from USFDA for Celecoxib: Angel Broking
Views on Tech Mahindra and Circle Health sign 10-year strategic deal: Angel Broking
World financial fears keep Asia firms in holding pattern
India Technology - Tapering growth and volatility weighing on valuations: Anand Rathi Financial Services


  
Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014